Chosa Oncology AB (CHOSA)

Chosa Oncology AB recorded one insider purchase during the past ninety days. CEO Peter Buhl acquired shares valued at 29,824.83 SEK on October 8, 2026. This transaction represents the sole recent activity, following previous acquisitions by the same executive. No sales occurred, and the company has not released a recent earnings report.
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Peter Buhl Chief Executive Officer (CEO)/Managing Directory Officer
Transaction date
Purchase
Price
325.78
Quantity 22,743
Value SEK4,800,204
Peter Buhl Chief Executive Officer (CEO)/Managing Directory Officer
Transaction date
Purchase
Price
253.07
Quantity 39,815
Value SEK2,998,102
Peter Buhl Chief Executive Officer (CEO)/Managing Directory Officer
Transaction date
Purchase
Price
443.49
Quantity 15,892
Value SEK1,929,938
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-10-21 2026-10-08 B Purchase

Chief Executive Officer (CEO)/Managing Directory

Officer
22,743
325.78
SEK4,800,204
22,743 325.78 SEK4,800,204
2026-07-17 2026-07-14 B Purchase

Chief Executive Officer (CEO)/Managing Directory

Officer
39,815
253.07
SEK2,998,102
39,815 253.07 SEK2,998,102
2023-09-13 2023-09-13 B Purchase

Chief Executive Officer (CEO)/Managing Directory

Officer
15,892
443.49
SEK1,929,938
15,892 443.49 SEK1,929,938